Absci (ABSI) Stock: Why It's Up Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $8.86 as of 1:16 PM ET, +3.81% vs the prior close of $8.54.
- Volume 1.38M shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Medpace (MEDP)Icon (ICLR)bioAffinity Technologies (BIAF)
ABSI jumps 3.8% to $8.86. Trading at $8.86 (intraday, 1:16 PM ET), +3.81% vs the prior close of $8.54. Day range $8.22–$8.99, opened at $8.50.
ABSI daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — ABSI jumps 3.8% to $8.86
- Trading at $8.86 (intraday, 1:16 PM ET), +3.81% vs the prior close of $8.54. Day range $8.22–$8.99, opened at $8.50.
- Volume was 1.38M shares, 0.4x its 50-day average of 3.61M — lighter than usual.
- Price is -4.9% vs its 50-day average ($9.33) and +42.7% vs its 200-day average ($6.21).
- 52-week range $2.24–$12.06; the current price sits at 67% of that range, 26.5% below the 52-week high.
Oct 19, 2026 — ABSI jumps 3.5% to $8.54
- Closed at $8.54, +3.52% vs the prior close of $8.25. Day range $8.40–$8.96, opened at $8.67.
- Volume was 2.76M shares, 0.8x its 50-day average of 3.60M.
- Price is -8.5% vs its 50-day average ($9.33) and +38.1% vs its 200-day average ($6.19).
- 52-week range $2.24–$12.06; today's close sits at 64% of that range, 29.2% below the 52-week high.
Oct 16, 2026 — ABSI slides 7.1% to $8.25, a 1-month low
- Closed at $8.25, -7.09% vs the prior close of $8.88. Day range $8.12–$8.95, opened at $8.93.
- Volume was 3.53M shares, 1.0x its 50-day average of 3.57M.
- Price is -11.6% vs its 50-day average ($9.34) and +33.9% vs its 200-day average ($6.16).
- 52-week range $2.24–$12.06; today's close sits at 61% of that range, 31.6% below the 52-week high.
Oct 15, 2026 — ABSI rises 1.6% to $8.88
- Closed at $8.88, +1.60% vs the prior close of $8.74. Day range $8.23–$8.94, opened at $8.43.
- Volume was 3.39M shares, 1.0x its 50-day average of 3.54M.
- Price is -4.9% vs its 50-day average ($9.34) and +44.7% vs its 200-day average ($6.14).
- 52-week range $2.24–$12.06; today's close sits at 68% of that range, 26.3% below the 52-week high.
Oct 14, 2026 — ABSI slides 4.0% to $8.74, 3 down days in a row
- Closed at $8.74, -3.96% vs the prior close of $9.10. Day range $8.62–$9.12, opened at $8.88.
- Volume was 3.55M shares, 1.0x its 50-day average of 3.51M.
- Price is -6.3% vs its 50-day average ($9.33) and +43.1% vs its 200-day average ($6.11).
- 52-week range $2.24–$12.06; today's close sits at 66% of that range, 27.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ABSI slides 5.9% to $9.10
- Closed at $9.10, -5.89% vs the prior close of $9.67. Day range $9.00–$9.66, opened at $9.44.
- Volume was 3.04M shares, 0.9x its 50-day average of 3.49M.
- Price is -2.4% vs its 50-day average ($9.32) and +49.6% vs its 200-day average ($6.08).
- 52-week range $2.24–$12.06; today's close sits at 70% of that range, 24.5% below the 52-week high.
Oct 12, 2026 — ABSI slides 4.8% to $9.67
- Closed at $9.67, -4.82% vs the prior close of $10.16. Day range $9.43–$10.09, opened at $10.06.
- Volume was 2.86M shares, 0.8x its 50-day average of 3.48M.
- Price is +4.0% vs its 50-day average ($9.30) and +59.7% vs its 200-day average ($6.06).
- 52-week range $2.24–$12.06; today's close sits at 76% of that range, 19.8% below the 52-week high.
Oct 9, 2026 — ABSI jumps 13.6% to $10.16
- Closed at $10.16, +13.65% vs the prior close of $8.94. Day range $8.93–$10.39, opened at $9.20.
- Volume was 4.24M shares, 1.2x its 50-day average of 3.47M.
- Price is +9.7% vs its 50-day average ($9.26) and +68.6% vs its 200-day average ($6.03).
- 52-week range $2.24–$12.06; today's close sits at 81% of that range, 15.7% below the 52-week high.
Oct 8, 2026 — ABSI slides 3.0% to $8.94, 3 down days in a row
- Closed at $8.94, -3.04% vs the prior close of $9.22. Day range $8.81–$9.27, opened at $9.04.
- Volume was 4.68M shares, 1.4x its 50-day average of 3.44M.
- Price is -3.0% vs its 50-day average ($9.21) and +49.2% vs its 200-day average ($5.99).
- 52-week range $2.24–$12.06; today's close sits at 68% of that range, 25.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ABSI slides 10.2% to $9.22
- Closed at $9.22, -10.22% vs the prior close of $10.27. Day range $9.12–$10.22, opened at $10.00.
- Volume was 5.85M shares, 1.7x its 50-day average of 3.38M.
- Price is +0.5% vs its 50-day average ($9.17) and +54.6% vs its 200-day average ($5.97).
- 52-week range $2.24–$12.06; today's close sits at 71% of that range, 23.5% below the 52-week high.
Oct 6, 2026 — ABSI slides 10.9% to $10.27
- Closed at $10.27, -10.93% vs the prior close of $11.53. Day range $10.21–$11.89, opened at $11.77.
- Volume was 5.88M shares, 1.8x its 50-day average of 3.32M.
- Price is +12.5% vs its 50-day average ($9.13) and +73.0% vs its 200-day average ($5.94).
- 52-week range $2.24–$12.06; today's close sits at 82% of that range, 14.8% below the 52-week high.
Oct 5, 2026 — ABSI jumps 4.2% to $11.53, a 3-month high
- Closed at $11.53, +4.16% vs the prior close of $11.07. Day range $10.87–$11.80, opened at $11.10.
- Volume was 4.29M shares, 1.3x its 50-day average of 3.28M.
- Price is +27.1% vs its 50-day average ($9.07) and +95.4% vs its 200-day average ($5.90).
- 52-week range $2.24–$12.06; today's close sits at 95% of that range, 4.4% below the 52-week high.
Oct 2, 2026 — ABSI rises 3.0% to $11.07, a 1-month high
- Closed at $11.07, +2.98% vs the prior close of $10.75. Day range $10.83–$11.35, opened at $11.14.
- Volume was 3.38M shares, 1.0x its 50-day average of 3.26M.
- Price is +23.1% vs its 50-day average ($9.00) and +88.8% vs its 200-day average ($5.86).
- 52-week range $2.24–$12.06; today's close sits at 90% of that range, 8.2% below the 52-week high.
ABSI bull case vs bear case (from the data)
- Price is +42.7% vs its 200-day average — above the long-term trend line.
- Insiders made 17 open-market purchases in the last 12 months.
- Price is -4.9% vs its 50-day average — short-term trend is down.
- Annual revenue fell 20.7% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $115.18M.
- Share count up 14.8% in a year (dilution).
- High volatility: average daily move of 5.6% over 20 sessions.
ABSI latest news & SEC filings
Every SEC filing by or about ABSI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mcclain Sean had withheld for taxes 23,293 shares at $10.16 (≈$236.66K) on Oct 12, 2026; now holds 8,632,262
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bedrick Todd had withheld for taxes 22,325 shares at $10.16 (≈$226.82K) on Oct 12, 2026; now holds 199,128
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jonasson Zachariah had withheld for taxes 387 shares at $10.16 (≈$3.93K) on Oct 12, 2026; now holds 484,918
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$33.21M (prior year -$30.57M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.21 (prior year -$0.24) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jun 24, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade ABSI
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 24, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.62% (largest 13.6%). That is a volatile stock.
- Liquidity: about 3.84M shares (≈$34.07M) trade per day on average.
- 52-week position: $8.86 vs a range of $2.24–$12.06 (67% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Mary T Szela bought 12,900 shares on Jun 30, 2026.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 8-K Jun 24, 2026.
- Share count: 171.61M shares outstanding (Jul 31, 2026), +14.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
ABSI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 8.50 | 8.99 | 8.22 | 8.86 | 1.38M |
| Oct 19, 2026 | 8.69 | 8.96 | 8.40 | 8.54 | 2.76M |
| Oct 16, 2026 | 8.93 | 8.95 | 8.12 | 8.25 | 3.55M |
| Oct 15, 2026 | 8.43 | 8.94 | 8.23 | 8.88 | 3.39M |
| Oct 14, 2026 | 8.88 | 9.12 | 8.62 | 8.74 | 3.55M |
| Oct 13, 2026 | 9.44 | 9.66 | 9.00 | 9.10 | 3.04M |
| Oct 12, 2026 | 10.06 | 10.09 | 9.43 | 9.67 | 2.86M |
| Oct 9, 2026 | 9.20 | 10.39 | 8.93 | 10.16 | 4.24M |
| Oct 8, 2026 | 9.04 | 9.27 | 8.81 | 8.94 | 4.68M |
| Oct 7, 2026 | 10.00 | 10.22 | 9.12 | 9.22 | 5.85M |
| Oct 6, 2026 | 11.77 | 11.89 | 10.21 | 10.27 | 5.88M |
| Oct 5, 2026 | 11.10 | 11.80 | 10.87 | 11.53 | 4.29M |
| Oct 2, 2026 | 11.14 | 11.35 | 10.83 | 11.07 | 3.38M |
| Oct 1, 2026 | 10.80 | 11.27 | 10.55 | 10.75 | 4.61M |
| Sep 30, 2026 | 10.35 | 10.99 | 10.04 | 10.77 | 5.43M |
| Sep 29, 2026 | 9.59 | 10.18 | 9.48 | 10.14 | 3.42M |
| Sep 28, 2026 | 9.57 | 9.67 | 9.25 | 9.49 | 3.25M |
| Sep 25, 2026 | 10.49 | 10.50 | 9.68 | 9.74 | 3.21M |
| Sep 24, 2026 | 9.55 | 10.39 | 9.30 | 10.35 | 3.39M |
| Sep 23, 2026 | 10.51 | 10.62 | 9.47 | 9.74 | 4.72M |
About Absci
Absci (ABSI) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in VANCOUVER, WA. Fiscal year ends December 31. SEC CIK 1672688.
ABSI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Karen K Mcginnis | Director | Jun 11, 2026 |
| Sean Mcclain | Chief Executive Officer | Jun 26, 2026 |
| Menelas N Pangalos | Director | Jun 8, 2026 |
| Daniel A Rabinovitsj | Director | Jun 8, 2026 |
| Joseph Sirosh | Director | Jun 8, 2026 |
| Mary T Szela | Director | Jul 6, 2026 |
| Houten Frans Van | Director | Jun 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Todd Bedrick | SVP, CAO | Mar 16, 2026 |
| Andreas Busch | Chief Innovation Officer | Mar 16, 2026 |
| Zachariah Jonasson | CFO / CBO | Sep 1, 2026 |
| Sean Mcclain | Chief Executive Officer | Jun 26, 2026 |
| Ransi Mudalinayake Somaratne | CMO, Head of R&D | Aug 7, 2026 |
| Shelby J. Walker | Chief Legal Officer | Mar 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 30, 2026 | Mary T Szela | Buy | 12,900 | $11.54 |
| Jun 30, 2026 | Mary T Szela | Buy | 12,900 | $11.54 |
| Jun 30, 2026 | Mary T Szela | Buy | 12,900 | $11.54 |
| Jun 30, 2026 | Mary T Szela | Buy | 12,900 | $11.54 |
| May 13, 2026 | Menelas N Pangalos | Buy | 37,453 | $5.36 |
| May 13, 2026 | Menelas N Pangalos | Buy | 37,453 | $5.36 |
| May 13, 2026 | Menelas N Pangalos | Buy | 37,453 | $5.36 |
| May 13, 2026 | Menelas N Pangalos | Buy | 37,453 | $5.36 |
| Mar 12, 2026 | Andreas Busch | Buy | 100,000 | $2.29 |
| Mar 12, 2026 | Andreas Busch | Buy | 100,000 | $2.29 |
| Mar 12, 2026 | Andreas Busch | Buy | 100,000 | $2.29 |
| Mar 12, 2026 | Andreas Busch | Buy | 100,000 | $2.29 |
| Feb 27, 2026 | Menelas N Pangalos | Buy | 75,095 | $2.74 |
| Feb 27, 2026 | Menelas N Pangalos | Buy | 75,095 | $2.74 |
| Feb 27, 2026 | Menelas N Pangalos | Buy | 75,095 | $2.74 |
ABSI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-115.18M | -0.84 | $-92.92M |
| Dec 31, 2024 | $4.53M | $-103.11M | -0.94 | $-72.40M |
| Dec 31, 2023 | $5.72M | $-110.57M | -1.20 | $-64.64M |
| Dec 31, 2022 | $5.75M | $-104.90M | -1.15 | $-81.34M |
| Dec 31, 2021 | $4.78M | $-100.96M | -2.08 | $-60.60M |
Latest balance sheet: total assets $268.92M, total liabilities $22.79M, cash $107.86M (as of Jun 30, 2026).
ABSI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $9.41 |
| May 7, 2026 | 8-K Item 2.02 (results) | $5.75 |
| Mar 24, 2026 | 8-K Item 2.02 (results) | $3.01 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $3.40 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $2.97 |
| May 13, 2025 | 8-K Item 2.02 (results) | $2.96 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $3.08 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $3.64 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 21, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Medpace (MEDP)Icon (ICLR)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)iSpecimen (ISPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ABSI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.